0000000000760050

AUTHOR

Ricci E.

showing 3 related works from this author

Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohor…

2019

Abstract Background Study aim was to evaluate the safety and durability of darunavir/cobicistat (DRV/c) in a real life setting. Methods Multicentre prospective cohort study performed in the context of SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals). Patients were evaluated at baseline, week 24 and 48. Changes were evaluated using the paired t test or signed rank test. The multivariable analysis was performed using a general linear model, after ranking of not normally distributed variables. Results A total of 249 patients were included, 72 (29%) were in DRV/c-based dual therapies (DT). Hypercholesterolemia, HC, (total cholesterol (TC) ≥ 200 mg/dL or low density-C (LDL-C) ≥ 13…

0301 basic medicineMaleHIV Infections0302 clinical medicineDualMedicineHIV InfectionPharmacology (medical)030212 general & internal medicineProspective StudiesProspective cohort studyDarunavirCobicistatMiddle AgedViral LoadTolerabilityTolerabilityAnti-Retroviral AgentsCohortMolecular MedicineDrug Therapy CombinationFemaleDarunavir/cobicistatHumanmedicine.drugAdverse eventAdultlcsh:Immunologic diseases. Allergymedicine.medical_specialty030106 microbiologyContext (language use)Durability03 medical and health sciencesDarunavir/cobicistat Dual Durability Tolerability CISAI Adverse eventsVirologyInternal medicineHumansDarunavirbusiness.industryResearchHypertriglyceridemiamedicine.diseaseCISAIDiscontinuationProspective StudieAdverse eventsHIV-1Anti-Retroviral AgentCobicistatbusinesslcsh:RC581-607
researchProduct

Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a dec…

2022

Objectives: The aim of this study was to assess the incidence of being overweight and metabolic syndrome (MS) among people living with HIV (PHIV) in three different cross-sectional studies conducted over three different periods: 2005, 2011 and 2015. Methods: This was a multi-centre, nationwide study. Data were collected in three studies from the CISAI group - SIMOne, HIV-HY and STOPSHIV - and included a total of 3014 PHIV. Logistic regression [odds ratio (OR), 95% confidence interval (CI)] was used to account for age and gender difference among three groups when comparing MS prevalence and being overweight; potential confounders were accounted for by including them in the regression equatio…

AdultMaledyslipidaemiaantiretroviral therapyHIV InfectionsOverweightLogistic regressionBody Mass IndexCohort StudiesPrevalencemedicineoverweightHumansPharmacology (medical)Metabolic Syndromebusiness.industryHealth PolicyIncidence (epidemiology)Body WeightHIVweight gainOdds ratioMiddle Agedmedicine.diseaseConfidence intervalHIV; antiretroviral therapy; dyslipidaemia; metabolic syndrome; overweight; weight gainCross-Sectional StudiesInfectious Diseasesweight gain.Metabolic syndromemedicine.symptombusinessWeight gainDemographyCohort studyHIV Medicine
researchProduct

Search for Magnetic Monopoles and Stable High-Electric-Charge Objects in 13 Tev Proton-Proton Collisions with the ATLAS Detector

2020

We thank CERN for the very successful operation of the LHC, aswell as the support staff fromour institutionswithout whom ATLAS could not be operated efficiently. We acknowledge the support of ANPCyT, Argentina; YerPhI, Armenia; ARC, Australia; FWF, BMWFW, Austria; ANAS, Azerbaijan; SSTC, Belarus; CNPq, FAPESP, Brazil; NSERC, CFI, NRC, Canada; CERN; CONICYT, Chile; CAS, NSFC, MOST, China; COLCIENCIAS, Colombia; VSC CR, MSMT CR, MPO CR, Czech Republic; DNSRC, DNRF, Denmark; IN2P3-CNRS, CEA-DRF/IRFU, France; SRNSFG, Georgia; MPG, HGF, BMBF, Germany; GSRT, Greece; RGC, Hong Kong SAR, Hong Kong China; Benoziyo Center, ISF, Israel; INFN, Italy; JSPS, MEXT, Japan; JINR; CNRST, Morocco; NWO, Nether…

electric [charge]Drell-Yan process:Kjerne- og elementærpartikkelfysikk: 431 [VDP]Magnetic monopolesProton13000 GeV-cmsPhysics::Instrumentation and Detectorselectromagnetic [calorimeter]magnetic [charge]General Physics and Astronomy7. Clean energy01 natural scienceschannel cross section: upper limitHigh Energy Physics - Experimentmagnetic monopole: massSubatomär fysikparticle: stabilityHigh Energy Physics - Experiment (hep-ex)magnetic monopole: pair productionSubatomic Physicsscattering [p p][PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]tracking detectorstability [particle]0 [spin]1/2 [spin]Particle productionHadron collidersPhysicsRange (particle radiation)Large Hadron Colliderupper limit [channel cross section]DetectorSettore FIS/01 - Fisica Sperimentalemass [magnetic monopole]ATLAS3. Good health:Nuclear and elementary particle physics: 431 [VDP]CERN LHC Collhigh [ionization]ATLAS Detectorslower limit [mass]atlas; lhc; higgs;colliding beams [p p]pair production [magnetic monopole]Particle Physics - ExperimentsignatureDirect Productionp p: scatteringHigh-Ionizationdirect production [magnetic monopole]530 PhysicsCiências Naturais::Ciências Físicasmass: lower limit:Ciências Físicas [Ciências Naturais]Magnetic monopolespin: 0FOS: Physical sciencesLHC ATLAS High Energy Physicsddc:500.2Electromagnetic CalorimeterElectric chargeComputer Science::Digital LibrariesChargeNuclear physicsionization: high0103 physical sciencesTransition Radiation Trackersddc:530High Energy Physicsspin: 1/2010306 general physicsCiencias ExactasATLAS Collaborationcharge: magneticmagnetic monopolesS028CScience & Technologyhep-excharge: electricFísicaCharge (physics)triggerPair productioncalorimeter: electromagneticProton Proton CollisionsExperimental High Energy PhysicsMagnetic ChargesElementary Particles and FieldsHigh Energy Physics::Experimenttransition radiationHadron-hadron collisionsp p: colliding beamsmagnetic monopole: direct productionexperimental resultsPhysical Review Letters
researchProduct